What does STERIGENICS BELGIUM (Petit Rechain) do?

STERIGENICS BELGIUM (Petit Rechain) is a cleaning company in Verviers. Private Limited, started on 16 March 1998, 1 establishment.

What is the address of STERIGENICS BELGIUM (Petit Rechain)?

The registered office of STERIGENICS BELGIUM (Petit Rechain) is located at Avenue André Ernst 21, 4800 Verviers.

Is STERIGENICS BELGIUM (Petit Rechain) still active?

Yes. According to the CBE (30 September 2026) STERIGENICS BELGIUM (Petit Rechain) is active, legal situation “Normale toestand”, started on 16 March 1998.

Is STERIGENICS BELGIUM (Petit Rechain) registered on Peppol?

Yes, STERIGENICS BELGIUM (Petit Rechain) is registered on the Peppol network with ID 0208:0462884493.

What is the enterprise number of STERIGENICS BELGIUM (Petit Rechain)?

The enterprise number of STERIGENICS BELGIUM (Petit Rechain) is BE0462884493.

When was STERIGENICS BELGIUM (Petit Rechain) founded?

STERIGENICS BELGIUM (Petit Rechain) was founded on 16 March 1998.

Who are the directors of STERIGENICS BELGIUM (Petit Rechain)?

According to the 2025 annual accounts, the directors of STERIGENICS BELGIUM (Petit Rechain) are: Frederic Bekaert, Robin Van Den Bergh.

Is STERIGENICS BELGIUM (Petit Rechain) a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 March 1998; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did STERIGENICS BELGIUM (Petit Rechain) make in 2025?

STERIGENICS BELGIUM (Petit Rechain) posted a profit after taxes of € 15,304,997 in financial year 2025.

What is the revenue of STERIGENICS BELGIUM (Petit Rechain)?

In its most recent annual accounts (2025), STERIGENICS BELGIUM (Petit Rechain) reported revenue of € 44,075,811.

How much does an employee at STERIGENICS BELGIUM (Petit Rechain) earn?

The average wage cost per full-time employee at STERIGENICS BELGIUM (Petit Rechain) was € 86,400 in 2025: staff costs of € 8.1 million for 93.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does STERIGENICS BELGIUM (Petit Rechain) have?

According to the 2025 annual accounts, STERIGENICS BELGIUM (Petit Rechain) has 93.8 full-time equivalents (FTE).

STERIGENICS BELGIUM (Petit Rechain) (Private Limited)

Dossier STERIGENICS BELGIUM (Petit Rechain), printed on 30 September 2026 from databakkes.be/en/0462884493/sterigenics-belgium-petit-rechain. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

STERIGENICS BELGIUM (Petit Rechain) from Verviers, company number BE0462884493, closed financial year 2025 with a result of € 15.3 million after tax. For that financial year STERIGENICS BELGIUM (Petit Rechain) recorded revenue of € 44.1 million and equity of € 64.9 million. Compared with financial year 2024, the result moved from € 13.9 million to € 15.3 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.

What it is worth Growing

€ 64.9 million

▲ 9% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 15.3 million

▲ 10% vs 2024

Profit after tax over the fiscal year.

Where the profit goes Pays out

€ 9.9 million paid out

65 % of the profit went to the shareholders, mostly to Nelson Labs NV (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

93.8

▲ 6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 12.6 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 8.1 million

▲ 19% vs 2024

€ 86,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 21,416

▼ 50% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1.7 million

▼ 21% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 42 days on average.

Taxes and wages

€ 1.7 million

▲ 27% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 32,241,859 Revenue 2022: € 32,241,859 First fiscal year in the series	€ 38,410,194 Revenue 2023: € 38,410,194 ▲ 19% vs 2022 (€ 32,241,859) Favourable step	€ 38,788,384 Revenue 2024: € 38,788,384 ▲ 1% vs 2023 (€ 38,410,194) Favourable step	€ 44,075,811 Revenue 2025: € 44,075,811 ▲ 14% vs 2024 (€ 38,788,384) Favourable step	▲ 14%
Profit after taxes	€ 11,509,526 Profit after taxes 2022: € 11,509,526 First fiscal year in the series	€ 13,293,966 Profit after taxes 2023: € 13,293,966 ▲ 16% vs 2022 (€ 11,509,526) Favourable step	€ 13,856,346 Profit after taxes 2024: € 13,856,346 ▲ 4% vs 2023 (€ 13,293,966) Favourable step	€ 15,304,997 Profit after taxes 2025: € 15,304,997 ▲ 10% vs 2024 (€ 13,856,346) Favourable step	▲ 10%
Equity	€ 67,451,864 Equity 2022: € 67,451,864 First fiscal year in the series	€ 80,701,537 Equity 2023: € 80,701,537 ▲ 20% vs 2022 (€ 67,451,864) Favourable step	€ 59,584,858 Equity 2024: € 59,584,858 ▼ 26% vs 2023 (€ 80,701,537) Unfavourable step	€ 64,920,324 Equity 2025: € 64,920,324 ▲ 9% vs 2024 (€ 59,584,858) Favourable step	▲ 9%
Total debts	€ 2,848,466 Total debts 2022: € 2,848,466 First fiscal year in the series	€ 3,817,216 Total debts 2023: € 3,817,216 ▲ 34% vs 2022 (€ 2,848,466) Unfavourable step	€ 5,168,467 Total debts 2024: € 5,168,467 ▲ 35% vs 2023 (€ 3,817,216) Unfavourable step	€ 4,080,699 Total debts 2025: € 4,080,699 ▼ 21% vs 2024 (€ 5,168,467) Favourable step	▼ 21%
Cash	€ 25 Cash 2022: € 25 First fiscal year in the series	€ 0 Cash 2023: € 0 ▼ 100% vs 2022 (€ 25) Unfavourable step	-	-
Land & buildings	€ 5,884,477 Land & buildings 2022: € 5,884,477 First fiscal year in the series	€ 5,583,973 Land & buildings 2023: € 5,583,973 ▼ 5% vs 2022 (€ 5,884,477) Unchanged	€ 5,430,093 Land & buildings 2024: € 5,430,093 ▼ 3% vs 2023 (€ 5,583,973) Unchanged	€ 5,250,599 Land & buildings 2025: € 5,250,599 ▼ 3% vs 2024 (€ 5,430,093) Unchanged	▼ 3%
Retained profit	€ 55,851,901 Retained profit 2022: € 55,851,901 First fiscal year in the series	€ 69,145,867 Retained profit 2023: € 69,145,867 ▲ 24% vs 2022 (€ 55,851,901) Favourable step	€ 48,063,225 Retained profit 2024: € 48,063,225 ▼ 30% vs 2023 (€ 69,145,867) Unfavourable step	€ 53,438,493 Retained profit 2025: € 53,438,493 ▲ 11% vs 2024 (€ 48,063,225) Favourable step	▲ 11%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 34,938,988 Dividend 2024: € 34,938,988 Unchanged (€ 0) Unchanged	€ 9,929,729 Dividend 2025: € 9,929,729 ▼ 72% vs 2024 (€ 34,938,988) Unchanged	▼ 72%
Balance sheet total	€ 70,419,833 Balance sheet total 2022: € 70,419,833 First fiscal year in the series	€ 84,623,492 Balance sheet total 2023: € 84,623,492 ▲ 20% vs 2022 (€ 70,419,833) Unchanged	€ 64,832,882 Balance sheet total 2024: € 64,832,882 ▼ 23% vs 2023 (€ 84,623,492) Unchanged	€ 69,063,523 Balance sheet total 2025: € 69,063,523 ▲ 7% vs 2024 (€ 64,832,882) Unchanged	▲ 7%
Employees (FTE)	87.2 Employees (FTE) 2022: 87.2 First fiscal year in the series	86 Employees (FTE) 2023: 86 ▼ 1.2 vs 2022 (87.2) Unchanged	87.8 Employees (FTE) 2024: 87.8 ▲ 1.8 vs 2023 (86) Unchanged	93.8 Employees (FTE) 2025: 93.8 ▲ 6 vs 2024 (87.8) Unchanged	▲ 6

Key figures of STERIGENICS BELGIUM (Petit Rechain), fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to STERIGENICS BELGIUM (Petit Rechain)?

What happened at STERIGENICS BELGIUM (Petit Rechain) in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2031 Robin Van Den Bergh stepped down as director. NBB
Jul 22, 2026 New annual accounts for financial year 2025: profit of € 15.3 million (▲ 10% vs 2024). Source: NBB ↗
2025 Robin Van Den Bergh became a director. NBB
2025 Frederic Bekaert stepped down as director. NBB
2019 Frederic Bekaert became a director. NBB
Apr 14, 1998 New establishment in Verviers. KBO
Mar 16, 1998 Start of the company according to the CBE. KBO

In short

From € 11.5 million profit in 2022 to € 15.3 million profit in 2025.

Paid € 19 million in corporate taxes since 2022.

Best year ever: 2025, with € 15.3 million profit.

Paid out € 44.9 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at STERIGENICS BELGIUM (Petit Rechain)? We notify you, reason included.

Follow STERIGENICS BELGIUM (Petit Rechain)

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Nelson Labs NV 100%

STERIGENICS 100%

The stake of STERIGENICS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

STERIGENICS BELGIUM (Petit Rechain)

Sterigenics Italy SPA Unipersonale 100%

Sterigenics France SAS 100%

STERIGENICS SHANGHAI EBeam Ltd 100%

The shares are held by Nelson Labs NV (100%) and STERIGENICS (100%). It owns 100% of Sterigenics Italy SPA Unipersonale, 100% of Sterigenics France SAS and 100% of STERIGENICS SHANGHAI EBeam Ltd itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Frederic Bekaert

Director

since 2019 · until 2025

Robin Van Den Bergh

Director

Also active at: STERIGENICS

since 2025 · until 2031

Shareholders

Nelson Labs NV

100%

STERIGENICS

100%

Participations

Sterigenics Italy SPA Unipersonale

100%

Sterigenics France SAS

100%

STERIGENICS SHANGHAI EBeam Ltd

100%

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue André Ernst 21

4800 Verviers

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0462.884.493

VAT number

BE 0462.884.493

Registered office

Avenue André Ernst 21, 4800 Verviers

Names & denominations

STERIGENICS BELGIUM (Petit Rechain)

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

16 March 1998

Peppol

Active · Active since 2 Jan 2026

Activities · NACE

Overige reiniging van gebouwen; industriële reiniging

Industriële reiniging

Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

View on CBE Public ↗ Annual accounts (NBB) ↗

STERIGENICS BELGIUM (Petit Rechain)

Financials

What happened to STERIGENICS BELGIUM (Petit Rechain)?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions